The company has established regional hubs in Singapore and Japan to better enable the industry’s growing need to conduct clinical trials in Asia and/or manage global trials from the region.
Local teams apply insights gained from Almac’s experience managing more than 10,000 trials around the world to design, implement and manage drug supply strategies and efficient technology solutions throughout the life of the study.
Almac CEO Alan Armstrong noted from protocol to patient to kit destruction, Almac delivers high quality, flexible and cost-effective solutions that enable a more comprehensive approach to trial supply management.
"No one else can provide the global scale, scope and reach required to optimize sponsors’ R&D investments across every facet of the supply chain — within Asia or around the world," Armstrong added.
Almac’s local teams support studies of all sizes and degrees of complexity, helping sponsors to achieve time-saving efficiencies, reduce costs and improve trial outcomes. Services are augmented by a secure, web-based interface to monitor trial execution anywhere in the world, multi-lingual technical and project teams, and an in-house 24x7x365 hotline connecting site staff to on-call clinicians and unblinding specialists.
By positioning operational resources within the same time zones as where trials are executed, Almac is able to resolve issues in less than 24 hours — which in turn eliminates communications delays and improves patient care.
Almac is strengthening its Asia Pacific offerings by establishing a new secondary packaging facility in Singapore that will open by the end of 2014.
Through this facility, the company will better enable just-in-time supply management and support drug pooling strategies, which further optimize the supply chain, minimize wastage and reduce costs.